Pharmaceuticals News

Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.

Pharmaceutical Companies Shift to Near-Shore Medicines Sourcing as Supply Chain Risks Intensify

With global supply chains under stress due to COVID-19 pandemic, European pharmaceutical companies and distributors are increasingly looking for alternative supply channels inside the EU block. - December 16, 2021 - Pipelinepharma

IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol

IVI Opens Public Comment Period for Major Depressive Disorder Model Draft Protocol

Nonprofit Seeks Input Into Data Sources and Technical Specifications to Guide Model Development; Will Hold December 15 Webinar to Overview Protocol and Public Comment Process - December 14, 2021 - Innovation and Value Initiative

‘Dr. Pam’ Gumbs to be Showcased in the Winter Issue of P.O.W.E.R. Magazine as a Woman of Distinction

‘Dr. Pam’ Gumbs to be Showcased in the Winter Issue of P.O.W.E.R. Magazine as a Woman of Distinction

‘Dr. Pam’ Gumbs of Berkeley, California will be showcased in the Winter issue of P.O.W.E.R. Magazine as a Woman of Distinction for her outstanding achievements and contributions for over 40 years in the pharmaceutical field. Each quarter, P.O.W.E.R. chooses four exceptional women for... - December 09, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

Mirror Biologics, Inc. Announces Close of a $14 Million Financing Round

This Funding will be Used, in Part, to Launch an Asian Phase II/III Randomized Controlled Registration Trial for Advanced Liver Cancer in Q1/2-2022. - December 09, 2021 - Mirror Biologics, Inc.

PharmStars Announces 2021 Accelerator Graduates

PharmStars Announces 2021 Accelerator Graduates

12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. - December 08, 2021 - PharmStars

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched

First Medical Food for the Dietary Management of Polycystic Kidney Disease Launched

Scientific breakthroughs for kidney disease lead to the launch of the first-ever medical food for the daily dietary management of Polycystic Kidney Disease (PKD). - December 06, 2021 - Santa Barbara Nutrients

Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201

Parvus Therapeutics, a biopharmaceutical company developing Navacim™ platform-based disease-specific immunoregulator therapeutics to treat autoimmune diseases by activating endogenous generation of disease-specific regulatory T cells (Tregs) without impairing normal immune system function,... - November 29, 2021 - Parvus Therapeutics U.S., Inc.

7 Key Takeaways from SMi’s 10th Annual Pharmaceutical Microbiology Conference

SMi Reports: SMi Group outlines seven key takeaways attendees can gain from joining the Pharmaceutical Microbiology Conference on 17 and 18 January 2021 in London, UK. - November 28, 2021 - SAE Media Group

Navigating the Challenges and Legal Landscapes of Parallel Trade

SMi presents its 16th annual Parallel Trade conference on the 21st and the 22nd March 2022. As the only parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade. - November 27, 2021 - SAE Media Group

LPA Statement Regarding Voxzogo™

LPA Statement Regarding Voxzogo™

Little People of America (LPA), the world’s oldest and largest support organization for people with dwarfism and their families, has been tracking biotechnical developments for the treatment of individuals with Achondroplasia. LPA President, Mark Povinelli, says, "With the FDA approval... - November 21, 2021 - Little People of America Inc.

Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles

Today Parvus announced it has entered into an agreement with Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organization (CDMO), for process development, scale-up and GMP manufacturing of NavacimTM nanoparticles, a key building block for all of our Navacim platform drug development candidates. - November 19, 2021 - Parvus Therapeutics U.S., Inc.

CANNA/Hemp Extraction Labs USA Announces Joint Venture Partnerships for Cannabis Cultivators/Growers and Cannapreneurs

CANNA/Hemp Extraction Labs USA (CHELUSA) announced today they are offering to finance and commission Cannabis Extraction Labs and Cannabis Cloning Labs in NM, NJ, AZ, IL, MT and VA. CHELUSA is looking to form strategic partnerships with Cultivators/Growers and Cannapreneurs in these key states. The... - November 18, 2021 - Hemp Extraction Labs USA

GENINVO Launches Centre of Excellence for Data Science and Analytics to Help Clients Unlock Insights Using Data Science

GENINVO, a leading provider of life sciences product and business solutions organization, announced the launch of a Centre of Excellence for Data Science and Analytics (DSA CoE). The DSA is a resolute team of experts comprising of life science and technology domains. Data Science and Analytics CoE... - November 18, 2021 - GenInvo, Inc.

PharmStars Announces Showcase Event for Inaugural Class

PharmStars Announces Showcase Event for Inaugural Class

PharmStars, a pharma-focused accelerator for digital health startups, announces the start of its 2021 Showcase Event. At the Showcase Event, the 12 startups in the accelerator’s current cohort will pitch their digital health solutions to PharmStars’ pharma members. The startups and pharma members will also have the opportunity to meet privately to discuss potential partnership opportunities. - November 17, 2021 - PharmStars

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics Announces Issuance of US Patent Covering Next Generation Therapeutic Vaccine Technology for Treatment of Cancer and Infectious Disease

Mirror Biologics, Inc., a private clinical stage biopharmaceutical company, today announces the issuance of US Patent No. 11,160,852, “Method of Vaccinating Using Allogeneic Cells,” covering methods for creating a next generation of therapeutic vaccines against cancers and infectious... - November 17, 2021 - Mirror Biologics, Inc.

Corinne E. Tobin, MD Joins New York Breast Imaging

Corinne E. Tobin, MD Joins New York Breast Imaging

New York Breast Imaging is pleased to announce the addition of Chief of Breast Imaging Corinne E. Tobin, MD, one of the most renowned and the first fellowship-trained breast imagers on Long Island. - November 15, 2021 - New York Breast Health

Exploring the Impact of Machine Learning and Artificial Intelligence in Drug Development from Discovery to Healthcare

SMi Group reports: the 3rd Annual AI in Drug Discovery is set to return to London in March 2022 with a key focus on the opportunities of machine learning and AI in drug development - November 14, 2021 - SAE Media Group

Strategies Used by Seniors to Reduce Drug Costs Report Released by AAMSI

A significant share of U.S. seniors seek a way to reduce their cost for prescribed medications reports the American Association for Medicare Supplement Insurance. "Medicare's Open Enrollment ends in three weeks, a chance for seniors to see if they can get better drug plan coverage for the... - November 12, 2021 - American Association for Medicare Supplement Insurance

Eyecheck Announces FDA IND Clearance of STRI Formula, the First-Ever Food-Based, Combination Product in the STRI Phase 2 Clinical Trial for COVID-19 Symptoms

Eyecheck intends to initiate the Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial to evaluate STRI Formula in non-hospitalized adults with COVID-19. This trial is expected to begin in November 2021. - November 04, 2021 - Eyecheck, Inc.

PharmStars Welcomes Sumitovant Biopharma as Its Newest Member

PharmStars Welcomes Sumitovant Biopharma as Its Newest Member

PharmStars, the only pharma-focused, member-based accelerator for digital health startups, is pleased to announce that Sumitovant Biopharma has become its newest pharma member, joining existing members including Boehringer Ingelheim, Eli Lilly and Company, and Novo Nordisk. PharmStars focuses on bridging the "pharma-startup gap." PharmStars provides startups with education and mentoring to help them engage with pharma as clients and partners. - November 03, 2021 - PharmStars

SMi Group Launches Robotics & Automation in Pharma Conference 2022 in London, UK

SMi Group reports: the inaugural Robotics and Automation Conference is convening on 21st and 22nd February 2022, in London, UK, with a key focus on significant leaps in the robotic automation field. - November 01, 2021 - SAE Media Group

PharmD Live® Ends October’s American Pharmacists Month

PharmD Live®, the pharmacist-led telehealth company focused on reducing adverse drug effects, ended an active American Pharmacist Month with a full slate of new material regarding the importance of pharmacists to the healthcare system. “October was a wonderful celebration of hardworking... - October 31, 2021 - PharmD Live

Pascal Biosciences Announces Financing

Pascal Biosciences Inc. (“Pascal” or the “Company”) (TSXV: PAS) (OTC: PSCBF) (FSE: 6PB-FF) is pleased to announce a non-brokered private placement financing of up to 9,000,000 units (each a “Unit”) of securities at a price of $0.10 per Unit for aggregate gross proceeds of up to $900,000.00 (the “Offering”). - October 29, 2021 - Pascal Biosciences

AiArthritis Alerted to Rheumatology Patients Being Forced to Sacrifice Their Treatments Due to COVID-19

AiArthritis Alerted to Rheumatology Patients Being Forced to Sacrifice Their Treatments Due to COVID-19

Many AiArthritis patients use biologic DMARDs to manage their condition, but responses vary per individual. The right therapy can be life-changing; disrupting continuity of care is strongly discouraged, as it can result in compromised quality of life and comorbid diseases. To accommodate hospital inventory needs for medication to treat severe COVID cases, chronically ill rheumatology patients worldwide are forced off their treatments... and they are angry. - October 28, 2021 - AiArthritis

WENO Exchange Announces BestRx as New Trading Partner

WENO Exchange Announces BestRx as New Trading Partner

New alliance makes BestRx 1st Retail Pharmacy System to accept eRxs from all US prescribers. - October 27, 2021 - Weno Exchange LLC

Military Space and Satellite Professional to Join Global MilSatCom Confex in Two Weeks

SMi Group reports: SMi Group proudly hosts the 23rd Annual Global MilSatCom Confex on 2nd to 4th November 2021 with a Disruptive Technology Focus Day on 1st November 2021. - October 22, 2021 - SAE Media Group

ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace

ASHP Case Study on Drugs in Short Supply Highlights MedShorts Online Marketplace

The American Society of Health-System Pharmacists (ASHP) published a case study citing financial and sourcing successes for health system pharmacies utilizing the MedShorts marketplace for direct access to drugs. The data-driven marketplace consumes and analyzes data from ASHP Drug Shortages to match pharmacy needs and alleviate shortage occurrences. Read the case study: https://www.ashp.org/products-and-services/database-licensing-and-integration/ashp-drug-shortages/medshorts-case-study - October 21, 2021 - MedShorts LLC

Conference Chair Di Morris, AstraZeneca Invites You to Join SMi's 10th Annual Pharmaceutical Microbiology Conference

SMi Reports: Conference Chair Di Morris, AstraZeneca invites industry experts to attend the 10th Anniversary of Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022. - October 20, 2021 - SAE Media Group

'Dr. Pam' Gumbs Honored as a Woman of Distinction for the Fourth Quarter of 2021 by P.O.W.E.R.

'Dr. Pam' Gumbs Honored as a Woman of Distinction for the Fourth Quarter of 2021 by P.O.W.E.R.

'Dr. Pam' Gumbs, of Berkeley, California, has been honored as a Woman of Distinction for the fourth quarter of 2021 by P.O.W.E.R.-Professional Organization of Women of Excellence Recognized. Each quarter, P.O.W.E.R. chooses four women for their distinction award. These four noteworthy women deserve... - October 14, 2021 - P.O.W.E.R. Professional Organization of Women of Excellence Recognized

Pipelinepharma Closes €1.3M Seed Round to Shift Pharmaceutical Dealmaking Online

The European B2B pharmaceutical marketplace closed a venture seed round led by Practica Capital. Iron Wolf Capital, Pandos and a group of angel investors also participated in the funding round. - October 09, 2021 - Pipelinepharma

Omni-HC Selected to Participate in “Audience Amplification” Workshop at Prestigious Global Medical Affairs Meeting

Omni Healthcare Communications has been selected by the Medical Affairs Professional Society to convene a workshop on scientific communication amplification at the MAPS 2022 Global Annual Meeting. - October 02, 2021 - Sunny Ayr Holdings

Zebra Technologies Recognizes Denali Advanced Integration for Supporting Front-Line Workers

Zebra Technologies Recognizes Denali Advanced Integration for Supporting Front-Line Workers

Denali Advanced Integration Honored with $5,000 Donation for Communities In Schools of Washington - September 30, 2021 - Denali Advanced Integration

Telaleaf and Little Green Pharma Sponsor First Cannabis Certificate Course for Doctors in Germany

Telaleaf Health Inc. (“Telaleaf” or the “Company”), a telemedicine company revolutionizing the delivery of cannabis care to patients, is pleased to announce a joint sponsorship with a leading global medical cannabis company, Little Green Pharma Ltd. (or “LGP”),... - September 22, 2021 - Telaleaf

WiCON Publishes the China Pharmaceutical Guide 2021 (16th Edition)

WiCON Publishes the China Pharmaceutical Guide 2021 (16th Edition)

WiCON International Group LLC, the publisher of well-known WiCON | Pharma China (www.pharmachinaonline.com), announced that its China Pharmaceutical Guide 2021 (16th Edition) is now officially published. Now in its 16th edition, China Pharmaceutical Guide 2021 is thoroughly updated with the latest ample data from many reputable sources, abundant analysis by leading industry experts, new regulations and more case studies. - September 21, 2021 - WiCON International Group LLC

Leading Microbiologists to Meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference

SMi Reports: Leading pharmaceutical microbiologists and industry experts to meet at SMi’s 10th Anniversary Pharmaceutical Microbiology UK Conference taking place in London on 17-18 January 2022. - September 21, 2021 - SAE Media Group

Nass Valley Announces Engagement with Stockhouse

Nass Valley Announces Engagement with Stockhouse

Nass Valley Gateway (CSE: NVG.CN) is excited to announce that the company has engaged Stockhouse Publishing Ltd. (“Stockhouse”) to assist with investor and brand awareness as well as market outreach as Nass Valley continues to achieve important milestones and grow its investor... - September 20, 2021 - Nass Valley

AHHC of NC Partners with National Minority Health Association to Mobilize Home Care, Home Health, Hospice & Palliative Care Staff in Fight Against COVID-19

AHHC of NC Partners with National Minority Health Association to Mobilize Home Care, Home Health, Hospice & Palliative Care Staff in Fight Against COVID-19

The Association for Home & Hospice Care of North Carolina (AHHC of NC) is pleased to announce that they have partnered with the National Minority Health Association (NMHA) to help launch the new Flex for Checks program as part of the ongoing fight against COVID-19. The Flex for Checks... - September 17, 2021 - Association for Home & Hospice Care of North Carolina

Risk Communication Expert Dr. Vincent Covello Launches Online Training

Risk Communication Expert Dr. Vincent Covello Launches Online Training

World-renowned risk communication practitioner Dr. Vincent Covello has launched Pathway to Risk, High-Concern, and Crisis Communication, an online, video-based course on the principles and tools of risk communication. - September 16, 2021 - Pathway Communication

SMi’s Aseptic Processing Conference Co-Chairs from F Ziel GmbH and SKAN AG Invite Attendees to Join the Virtual Event in 2 Weeks

SMi Group reports: Conference co-chairs invite aseptic processing experts to join the virtual Aseptic Processing Conference in two weeks. - September 06, 2021 - SAE Media Group

Importance of Understanding Injection Device Needs in Rare Disease Patients

SMi Reports: Hear from key industry players from San Francisco and the West Coast to learn about Device Innovations, Connected Delivery and Regulatory Guidance for Advanced Parenteral Systems. - August 26, 2021 - SAE Media Group

Allegiant Health Offers a Wide Range of Laxative and Anti-Gas Products for Adults with Digestive Issues

Allegiant Health Offers a Wide Range of Laxative and Anti-Gas Products for Adults with Digestive Issues

The pharmaceutical launches products to help millions of adults in the U.S. suffering from bloating, constipation, and stomach problems. - August 25, 2021 - HealthA2Z

Free Exclusive Webinar on "Multiscale and Multi-Modal Insights Into Drug Formulation" - Join the Experts

SMi Reports: A free webinar led by Zeiss will take place on 7th September2021 to explore new approaches using X ray Microscopy (XRM) from nano- to micro-scale. - August 25, 2021 - SAE Media Group

Omni Healthcare Communications & Res Consortium Form Alliance to Expand Medical Affairs Capabilities

Omni Healthcare Communications (Omni-HC), a US based medical communications firm delivering solutions for today’s scientific exchange challenges, is pleased to announce the formation of a strategic alliance with Res Consortium (Res) of the United Kingdom, a cross-sector leader in digital... - August 21, 2021 - Sunny Ayr Holdings

HCS Pharma Opens Representative Office in Taiwan and Joins National Health Research Institutes Incubator

Biotech startup HCS Pharmais entering into incubation at the prestigious NHRI (National Health Research Institutes) in Taiwan. There, it will develop collaborations to put its exclusive BIOMIMESYS® technology at the service of the country's four major scientific research institutions. HCS Pharma has also opened a representative office in Taiwan, headed by Joseph Chou. - August 19, 2021 - HCS Pharma

Explore New Discoveries in the Treatment of Ocular Disease

SMi Group reports: 4th Annual Ophthalmic Drugs Conference taking place on the 22nd-23rd of November 2021, in London. - August 19, 2021 - SAE Media Group

Cancer Expert Now Ranks No. 333 as Inc. Magazine Reveals Their Annual List of America’s Fastest-Growing Private Companies - the Inc. 5000

Cancer Expert Now Ranks No. 333 as Inc. Magazine Reveals Their Annual List of America’s Fastest-Growing Private Companies - the Inc. 5000

Inc. magazine revealed today that Cancer Expert Now (CEN) is No. 333 on its annual Inc. 5000 list of the fastest-growing privately held companies in the United States. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment - its... - August 18, 2021 - Cancer Expert Now, Inc.

Dr. Justice E. Obi Honored as a VIP Member for 2021 by Strathmore's Who's Who Worldwide Publication

Dr. Justice E. Obi Honored as a VIP Member for 2021 by Strathmore's Who's Who Worldwide Publication

Dr. Justice E. Obi of Brooklyn, New York has been honored as a VIP Member for 2021 by Strathmore’s Who’s Who Worldwide for his outstanding contributions and achievements in the fields of Biotechnology and pharmaceuticals. About Dr. Justice E. Obi Dr. Justice Obi is a doctor and... - August 18, 2021 - Strathmore Worldwide

HealthA2Z’s Main Product, Aspirin 81 mg, Becomes an Amazon Choice Product

HealthA2Z’s Main Product, Aspirin 81 mg, Becomes an Amazon Choice Product

Allegiant Health takes the OTC healthcare market by storm with its FDA-registered drugs and supplements. - August 10, 2021 - HealthA2Z

10 Key Reasons to Join SMi's 2nd Annual Next Generation Pharmaceutical Cleanroom Conference

SMi Group reports: Ten key reasons to join SMi’s Next Generation Pharmaceutical Cleanroom conference, convening on 6th and 7th October 2021. - August 07, 2021 - SAE Media Group

The Latest Innovations in Digital Health and On-Body Drug Delivery for the Pharmaceutical Industry

SMi Group reports: Explore design strategies for connectivity and digital health at Wearable Injectors and Connected Devices conference 2021. - August 05, 2021 - SAE Media Group

Press Releases 151 - 200 of 2,687